Telmisartan versus amlodipine in hypertensive patients with paroxymal atrial fibrillation and different left atrial sizes

Trial Profile

Telmisartan versus amlodipine in hypertensive patients with paroxymal atrial fibrillation and different left atrial sizes

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Apr 2012

At a glance

  • Drugs Telmisartan (Primary) ; Amlodipine
  • Indications Hypertension; Paroxysmal atrial fibrillation
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Nov 2011 Results presented at the 84th Annual Scientific Sessions of the American Heart Association.
    • 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.
    • 12 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top